IPP Bureau
Emcure launches EmWocal campaign to raise women’s health issues
By IPP Bureau - May 10, 2022
The campaign will be available in nine Indian languages namely Hindi, English, Odia, Marathi, Tamil, Telugu, Kannada, Malayalam and Bengali
Novo Nordisk and Flagship Pioneering partner to create a portfolio of transformational medicines
By IPP Bureau - May 10, 2022
Pioneering Medicines and Novo Nordisk Bio Innovation Hub will leverage Flagship Pioneering’s bioplatform companies to create a portfolio of research programmes within cardiometabolic and rare diseases
Lonza, ALSA Ventures collaborate on providing manufacturing services to biotech firms
By IPP Bureau - May 10, 2022
The new framework collaboration will support due diligence into ALSA’s potential investments, which will assist with their investment de-risking
Omega Healthcare to expand operations in India
By IPP Bureau - May 10, 2022
Omega plans to further strengthen its capabilities, deepen domain expertise and build new solutions
Bora Pharmaceuticals acquires Eden Biologics CDMO assets
By IPP Bureau - May 10, 2022
Bora establishes a leadership position in Taiwan's CDMO sector as it continues to expand into the global CDMO market
CEPI partners with Bharat Biotech, Unversity of Sydney and ExcellGene to develop variant proof Covid-19 vaccine
By IPP Bureau - May 10, 2022
CEPI will provide funding of up to US $19.3 million to support the development of a ‘variant-proof’ SARS-CoV-2 vaccine candidate to an international multidisciplinary consortium
Pfizer to acquire Biohaven Pharmaceuticals for US $ 11.6 billion
By IPP Bureau - May 10, 2022
Pfizer to commercialize NURTEC ODT (rimegepant), an innovative compound for the prevention and acute treatment of migraine, a condition with high unmet need
Glenmark receives tentative ANDA approval for Calcipotriene and Betamethasone Dipropionate
By IPP Bureau - May 09, 2022
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
InxMed raises US $ 15 million in Series B+ financing
By IPP Bureau - May 09, 2022
The plan is to advance innovative therapies to drug-resistant cancers
ExoCoBio receives Japanese patent for alleviating dermatitis
By IPP Bureau - May 09, 2022
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
SCG Cell Therapy announces HSA clinical trial approval of TCR-T cell therapy for liver cancer
By IPP Bureau - May 09, 2022
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
Strengthening the access to rare disease treatment in India
By IPP Bureau - May 09, 2022
Takeda and United Nations Global Compact Network of India (UNGCNI) join hands
Datar Cancer Genetics signs US $ 250 million contract with Artemis DNA
By IPP Bureau - May 09, 2022
Under the 5-year exclusive agreement, Artemis DNA will provide Datar's pioneering cancer detection Liquid Biopsies in the USA and Vietnam markets
Roche Diabetes Care launches ACCU-FINE pen needles for virtually painless insulin delivery
By IPP Bureau - May 09, 2022
Aims to increase compliance and improve outcomes for People with Diabetes (PwD)
Nanavati-Max Hospital, Mumbai to expand capacity by over 600 beds
By IPP Bureau - May 09, 2022
The new building is expected to be commissioned by 2024. Post the expansion, Nanavati-Max Hospital will be amongst the largest private sector hospital in western India
